Borse di studio internazionali rinnovate negli Stati Uniti nel 2002-2003:
Borse di studio finanziate dai volontari dell’AICF
  • Rita Mancini, PhD
    Con Carlo M. Croce, M.D.
    Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia
    “Role of Fhit loss of function in early hyperproliferation and tumor progression”

Borsa di studio “Fondo Leo A. Shifrin, MD and Rosalyn Myers”
  • Loredana Fiorentino, PhD
    Con John C.Reed, MD PhD
    The Burnham Institute Apoptosis and Cell Death Program, San Diego
    “Role of ZIP Kinase in apoptosis and breast cancer”
Borsa di studio “Joseph and Amy Perella”
  • Paola de Candia, PhD
    Con Roberta Benezra, PhD
    Memorial Sloan-Kettering Cancer Center, New York City
    “The role of Id in the Vascularization of Breast Cancer”
Borsa di studio “Nicola Bulgari”
  • Silvia Grisendi, PhD
    Con Pier Paolo Pandolfi, MD Phd
    Memorial Sloan-Kettering Cancer Center- Cornell University, New York City
    Department of Human Genetics
    “Translational contributions in Tumorigenesis”
Borsa di studio Ortho Biotech Inc.
  • Francesco Guido, MD
    Con Micheal Karin, PhD
    University of California, San Diego, Department of Pharmacology
    “ASK1 activation: Role in oxidative stress mediated oncogenic transformation”
Borse di studio internazionali negli Stati Uniti 2002-2003:
Borse di studio negli Stati Uniti
  • Katia Basso, PhD
    Con Riccardo Dalla-Favera, MD
    Institute for Cancer Genetics- Columbia University, New York City
    “Gene expression profiling of IL- 4 signaling in normal and neoplastic B cells”
  • Vittoria Criniti, PhD
    Columbia University
    Con Lily Yamasaki, M.D.
    “Construction of a Conditional DP1 Knock-out Mouse”
  • Clara Guerzoni, PhD
    Thomas Jefferson University, Kimmel Cancer Center
    Con il Professor Massimo Federico
    “Role of the BCR/;ABL Oncogen in Suppression of Myeloid Differentation”
  • Giorgia Giunchi, PhD
    Memorial Sloan-Kettering Cancer Center
    Con Virgilio Sacchini, MD
    “Hormone Replacement Therapy and Low-dose Tamoxifen. A phase III trial of breast cancer prevention with low-dose tamoxifen in HRT users”
  • Nunzio Bottini, M.D
    Con Paolo Curatolo, M.D.
    “ Regulation of tuberin tumor suppressor by tyrosine phosphorylation: role of intracellular protein tyrosine phosphatases”
600